Our client is pioneering a new era of digital cardiology. Their flagship technology applies machine learning to the human voice to detect heart-failure worsening earlier than any existing method, transforming how clinicians monitor and manage their patients.

Building on a strong foundation of international clinical trials and the recent FDA Breakthrough Device Designation, they are now entering the next chapter: bringing this breakthrough technology to market and expanding the clinical evidence base to establish their technology as the new standard of care. Together with their deployed remote monitoring platform, already trusted by more than 200 cardiologists and over 1,000 patients across Europe and the United States, they are building the future of cardiovascular care.

About the Role

They are looking for a Scientific Founder’s Associate to work directly with their founders, especially their Chief Medical Officer, on some of the most import...